Support BIDMC’s COVID-19 Recovery Initiatives
As we navigate the greatest challenge in our history, philanthropic support is critically needed. Learn more about our extraordinary COVID-19 efforts and how you can help us. Give Now.
Your Giving Matters
Healthcare Heroes
Support our dedicated staff as they work day and night to ensure extraordinary care for all
Learn More
Research
Give today to the most brilliant minds in medicine who are finding innovative solutions for today’s most pressing global health challenges
Learn More
ICU Campaign
Fund our new inpatient building, which will enhance our critical care capacity with an entire ICU floor
Learn More
More BIDMC COVID-19 News
Johnson & Johnson says COVID-19 booster dose dramatically increases protection
Boston Globe – September 21, 2021 According to data released by the company, people who receive a Johnson…
Read More
A key part of Biden’s plan to combat Covid is at risk as FDA meets to debate booster shots
CNBC – September 17, 2021 A key FDA panel is set to meet today to debate and vote…
Read More
How COVID-19 hybrid immunity could be a potential pandemic game-changer
ABC News – September 17, 2021 Researchers are pointing to preliminary data suggesting that mixing different vaccines could…
Read More#BIDMCSocial
View the latest updates, information, and stories of hope from Beth Israel Deaconess Medical Center and across the Beth Israel Lahey Health system. Like, share and comment!
Next Thursday is International Translation Day!
We're excited to have our Interpreter Services team take over our Instagram account. Be sure to follow us on Instagram to check it out!
www.instagram.com/bidmchealth/
*Photo taken prior to COVID-19 pandemic
Douglas Scaffidi of Boston, a clinical research assistant and emergency department technician, is running the 125th Boston Marathon in honor of his fellow Healthcare Heroes at Beth Israel Deaconess Medical Center.
"Working clinically in the Emergency Department for the entirety of COVID, I saw the toll that this pandemic took on my coworkers and our community. Despite all that we faced, we were able to show our community that we had their back and that we were always going to show up in moments of need. For this reason, few things could make me more proud than to run the streets of New England with that logo on my chest and show the world the kind of grit that is on display every day at BIDMC.”
To learn more about all our runners on #TeamBILH click here: bit.ly/3nF4A9i
Anthony Cedeno is one of our trusted Information Systems gurus and today on #NationalITProfessionalsDay we wanted to show him and the rest of our amazing IS team some love!
"The number one reason I love my job is the customers/users. When I am able to fix whatever issue the person or department is having, that puts a smile on my face. Oh best believe, I get a run for my money most times, but I always say, 'don’t worry I got you' 😉 "
So cool!
Recently, John Kerry, the 68th United States Secretary of State and the Special Presidential Envoy for Climate, and Mary Rice, MD, MPH, Director of the Institute for Lung Health at BIDMC, participated in a panel discussion at Harvard Medical Grand Rounds. Click ⤵️ to watch a video replay of the event.
bit.ly/3nMCQQl
This week, we're celebrating the behind-the-scenes heroes on our Environmental Services Team! 👏 We are so grateful for your hard work and dedication to maintaining the health, safety, and cleanliness of our clinical and administrative areas. Thank you for all you do!
As we enter into Yom Kippur, we recognize and honor this time for our Jewish staff, patients, and community members to reflect and fast on this holy day.
We wish you a meaningful fast. G'mar chatima tova.
A new analysis by a team of physician-researchers at BIDMC published in the Journal of General Internal Medicine, provides the first evidence that monoclonal antibodies were indeed underutilized in the first six months of FDA authorization.
Read more: bit.ly/3lfS65c
ICYMI: In a research letter recently published in JAMA, physician-researchers at BIDMC found that the vast majority of patients who had one or more conditions like cognitive impairment, Alzheimer's disease, or cardiovascular disease, prior stroke, use of blood thinners, and age over 85 years would have been excluded from the aducanumab clinical trials. Read more ⤵️
#alzheimersdisease
bit.ly
BIDMC researchers find that majority of patients with Alzheimer’s disease would not have been eligible for the aducanumab clinical trials. Read more.Congratulations to BIDMC dermatologist Alexa B. Kimball, MD, MPH, President and CEO of Harvard Medical Faculty Physicians (HMFP) who has received the Lifetime Achievement Award from the National Psoriasis Foundation for her contributions to caring for those impacted by psoriasis through her research, teaching and clinical efforts. Read the full press release ⬇️
www.bidmc.org
BIDMC’s Dr. Kimball receives the Lifetime Achievement Award from the National Psoriasis Foundation for her commitment to those impacted by psoriasis.Words of Encouragement
Share a message of encouragement and support for our healthcare heroes
This is a moderated board. Your message will appear once it has been reviewed. Posts may be modified or not included to protect privacy. Thank you for sharing your support!
.
Thank You
We are so grateful for your support during these unprecedented times. Your quick response is funding our efforts to fight the COVID-19 pandemic and giving us the flexibility we need to address this critical situation.
As we continue to provide extraordinary care to our patients, we are overwhelmed by the outpouring of support we have received from the community.
Please watch this message of thanks from Marsha Maurer, DNP, RN, Senior Vice President for Patient Care Services, Cynthia and Robert J. Lepofsky Chief Nursing Officer and Incident Commander for the COVID-19 response at BIDMC.